tiprankstipranks
Celadon Pharmaceuticals PLC (GB:CEL)
LSE:CEL
UK Market

Celadon Pharmaceuticals PLC (CEL) Financial Statements

3 Followers

Celadon Pharmaceuticals PLC Financial Overview

Celadon Pharmaceuticals PLC's market cap is currently ―. The company's EPS TTM is p-0.311; its P/E ratio is -3.57; Celadon Pharmaceuticals PLC is scheduled to report earnings on September 26, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Aug 21Feb 21Aug 20Feb 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.08M$ 6.81M$ 6.96M$ 5.49M$ 5.55M
Total Assets$ 16.44M$ 6.82M$ 6.99M$ 5.50M$ 5.57M
Total Debt$ 4.59M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -4.49M$ -6.81M$ -6.96M$ -5.49M$ -5.55M
Total Liabilities$ 5.78M$ 56.13K$ 55.82K$ 41.72K$ 27.69K
Stockholders Equity$ 11.13M$ 6.76M$ 6.93M$ 5.46M$ 5.54M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Celadon Pharmaceuticals PLC Earnings and Revenue History

Celadon Pharmaceuticals PLC Debt to Assets

Celadon Pharmaceuticals PLC Cash Flow

Celadon Pharmaceuticals PLC Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis